Genor Biopharma Holdings Limited Financial Overview
Genor Biopharma Holdings Limited's market cap is currently €1.85B. The company's EPS TTM is HK$-0.112; its P/E ratio is 76.35; Genor Biopharma Holdings Limited is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
